BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Diagnosis
1928 results:

  • 1. Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study.
    Guo DZ; Huang A; Wang YC; Zhou S; Wang H; Xing XL; Zhang SY; Cheng JW; Xie KH; Yang QC; Ma CC; Li Q; Chen Y; Su ZX; Fan J; Liu R; Liu XL; Zhou J; Yang XR
    Clin Transl Med; 2024 May; 14(5):e1652. PubMed ID: 38741204
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma.
    Golam RM; Khalil MAF; Shaker OG; Ahmed TI; Elguaad MKA; Hassan EA; El-Ansary MRM; Ismail A; Kandil YI; Mohammed OA; Doghish AS
    PLoS One; 2024; 19(5):e0303314. PubMed ID: 38739668
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Usefulness of Vitamin K-Dependent Proteins in the diagnosis of Colorectal Carcinoma.
    Perné MG; Sitar-Tăut AV; Orășan OH; Negrean V; Vlad CV; Alexescu TG; Milaciu MV; Ciumărnean L; Togănel RD; Petre GE; Șimon I; Crăciun A
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732222
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Early detection of HCC in patients with cirrhosis using AI; a Systematic Review.
    Khursheed AA; Khan MR
    J Pak Med Assoc; 2024 Apr; 74(4 (Supple-4)):S29-S36. PubMed ID: 38712406
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A retrospective clinical analysis of 11 cases of PEComa from different sites.
    Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
    World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. An assessment of risk factors for recurrence and survival for patients undergoing liver resection for intrahepatic cholangiocarcinoma.
    Öztürk NB; Jamil LH
    Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):766-774. PubMed ID: 38683193
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Feasibility Study of Computed Tomographic Radiomics Model for the Prediction of Early and Intermediate Stage Hepatocellular Carcinoma Using BCLC Staging.
    Dong H; Yang L; Shaofeng D; Lili G
    Technol Cancer Res Treat; 2024; 23():15330338241245943. PubMed ID: 38660703
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Retrospective analysis of the incidence of appendiceal neoplasm and malignancy in patients treated for suspected acute appendicitis.
    Dohner E; Kierdorf FJ; Langer R; Zuber M; Fahrner R
    BMC Surg; 2024 Apr; 24(1):121. PubMed ID: 38658891
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diagnostic performance of PIVKA-II in identifying recurrent hepatocellular carcinoma following curative resection: a retrospective cohort study.
    Zhu W; Wang W; Zheng W; Chen X; Wang X; Xie J; Jiang S; Chen H; Zhu S; Xue P; Jiang X; Li H; Wang G
    Sci Rep; 2024 Apr; 14(1):8416. PubMed ID: 38600210
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Multiscale and multiperception feature learning for pancreatic lesion detection based on noncontrast CT.
    Yan T; Tang G; Zhang H; Liang L; Ma J; Gao Y; Zhou C; Li S
    Phys Med Biol; 2024 May; 69(10):. PubMed ID: 38588676
    [No Abstract]    [Full Text] [Related]  

  • 11. UBE2C: A pan-cancer diagnostic and prognostic biomarker revealed through bioinformatics analysis.
    Jalali P; Samii A; Rezaee M; Shahmoradi A; Pashizeh F; Salehi Z
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2032. PubMed ID: 38577722
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced liver MRI.
    Yoon JH; Kim YK; Kim JW; Chang W; Choi JI; Park BJ; Choi JY; Kim SS; Park HS; Lee ES; Yu JS; Park SJ; You MW; Lee CH; Lee JM
    Radiology; 2024 Apr; 311(1):e233114. PubMed ID: 38563667
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A new biomarker panel for differential diagnosis of cholangiocarcinoma: Results from an exploratory analysis.
    Köhler B; Bes M; Chan HL; Esteban JI; Piratvisuth T; Sukeepaisarnjaroen W; Tanwandee T; Thongsawat S; Mang A; Morgenstern D; Swiatek-de Lange M; Dayyani F
    Int J Biol Markers; 2024 Jun; 39(2):107-117. PubMed ID: 38549363
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer.
    Franceschini D; Franzese C; Comito T; Ilieva MB; Spoto R; Marzo AM; Dominici L; Massaro M; Bellu L; Badalamenti M; Mancosu P; Scorsetti M
    Radiother Oncol; 2024 Jun; 195():110240. PubMed ID: 38522597
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis.
    Cigrovski Berkovic M; Coppola A; Sesa V; Mrzljak A; Lai Q
    World J Gastroenterol; 2024 Feb; 30(7):759-769. PubMed ID: 38515954
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Research on multi-model imaging machine learning for distinguishing early hepatocellular carcinoma.
    Ma Y; Gong Y; Qiu Q; Ma C; Yu S
    BMC Cancer; 2024 Mar; 24(1):363. PubMed ID: 38515051
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Optimizing LI-RADS: ancillary features screened from LR-3/4 categories can improve the diagnosis of HCC on MRI.
    Zhang ZX; Xv H; Du YN; Lv ZB; Yang ZH
    BMC Gastroenterol; 2024 Mar; 24(1):117. PubMed ID: 38515017
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic cancer: A Multicenter Cohort Study.
    Huang J; Gao G; Ge Y; Liu J; Cui H; Zheng R; Wang J; Wang S; Go VL; Hu S; Liu Y; Yang M; Sun Y; Shang D; Tian Y; Zhang Z; Xiang Z; Wang H; Guo J; Xiao GG
    Dig Dis Sci; 2024 Apr; 69(4):1263-1273. PubMed ID: 38451429
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The role of baseline 2-[
    Albano D; Calabrò A; Dondi F; Bagnasco S; Tucci A; Bertagna F
    Hematol Oncol; 2024 Mar; 42(2):e3266. PubMed ID: 38444261
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Survival Among Patients With High-Risk Gastrointestinal cancers During the COVID-19 Pandemic.
    Janczewski LM; Browner AE; Cotler JH; Palis BE; Chan K; Joung RH; Bentrem DJ; Merkow RP; Boffa DJ; Nelson H
    JAMA Netw Open; 2024 Mar; 7(3):e240160. PubMed ID: 38441896
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 97.